Congenital and acquired thrombophilia are associated with an increased risk
of pregnancy-associated venous thrombosis and fetal loss. Two hundred eigh
ty-nine patients with a history of recurrent spontaneous abortion were subj
ected to screening examinations for the etiology of these abortions. Endocr
ine abnormality (28.0%), uterine abnormality (10.4%), autoimmune diseases (
1.4%), antiphospholipid antibody syndrome (4.5%), and balanced type chromos
ome translocation (4.2%) were found as underlying causes of recurrent abort
ions, and the remaining 55.0% of the 289 patients were classified as having
an unexplained etiology. Congenital thrombophilia such as protein C (PC) d
eficiency, protein S (PS) deficiency, antithrombin deficiency, and factor V
Leiden mutation was not frequently detected; only one patient had PS defic
iency. A reduced factor XII activity was found at a frequency of 4.2%. The
frequency of methylene tetrahydrofolate reductase gene C677T mutation in re
current aborters (0.38) was the same as that found in a fertile control gro
up. Although the prevalence of anti-beta2-glycoprotein I antibody (a beta2-
GPI) syndrome was very low (1.7%), patients with a high titer of immunoglob
ulin G (IgG) class a beta2-GPI, despite anticoagulation therapy, experience
d severe fetomaternal complications in subsequent pregnancies. The rate (13
.8%) of positive tests for serum IgA class a beta2-GPI in patients with une
xplained etiology was higher than that in the controls (0%) (P < .05). We c
onclude that congenital thrombophilia is rare in Japanese patients who had
experienced consecutive spontaneous abortions.